Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-041403

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey L Wade
Officer — EVP, Corp Adm Affairs and CFO
Period of report
Feb 11, 2016
Accepted (ET)
Feb 16, 2016 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———29,259D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$8.20Feb 11, 2016A71,940A—Feb 11, 2026Common Stock71,94071,940D
Restricted Stock Units (Phantom Stock)F2,F3—Feb 11, 2016A17,980A——Common Stock17,98017,980D
Stock Option (Right to Buy)F4$12.67holding————Feb 23, 2021Common Stock42,85742,857D
Stock Option (Right to Buy)F5$12.60holding————Feb 15, 2022Common Stock44,57144,571D
Stock Option (Right to Buy)F6$14.63holding————Feb 8, 2023Common Stock38,85638,856D
Restricted Stock Units (Phantom Stock)F2,F7—holding—————Common Stock4,8574,857D
Stock Option (Right to Buy)F8$12.04holding————Feb 6, 2024Common Stock46,85646,856D
Restricted Stock Units (Phantom Stock)F2,F9—holding—————Common Stock8,7858,785D
Stock Option (Right to Buy)F10$6.23holding————Feb 5, 2025Common Stock92,91492,914D
Restricted Stock Units (Phantom Stock)F2,F11—holding—————Common Stock23,22823,228D
Stock Option (Right to Buy)F12$27.58holding————Feb 13, 2017Common Stock17,14217,142D
Stock Option (Right to Buy)F13$14.49holding————Feb 7, 2018Common Stock28,57128,571D
Stock Option (Right to Buy)F14$10.15holding————Feb 12, 2019Common Stock53,57153,571D
Stock Option (Right to Buy)F15$10.64holding————May 17, 2020Common Stock14,28514,285D
Stock Option (Right to Buy)F16$13.30holding————Feb 15, 2020Common Stock53,57053,570D

Explanation of responses